Business   

Pfizer finalises pact for Protinex brand

MUMBAI NOV. 27. Pursuant to a global deal, Pfizer in India has finalised phased sales transition and manufacturing support agreements for Protinex with its EAC Nutrition's Indian subsidiary, EAC Trading Pvt. Ltd.

These moves, which would launch EAC Nutrition in the Indian market, involve phased sharing of revenues and profits and manufacturing of Protinex over a three-year period commencing December 1, in addition to outright consideration of $7 million to the Indian affiliate, Pfizer informed the Bombay Stock Exchange today.

This agreement follows Pfizer Products Inc, U.S., and Pfizer Corporation Panama's sale of Dumex (R) trademark and the protein supplement brand Protinex (R) to EAC Nutrition Limited, A/S, Denmark, it added. — PTI

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary |

Stories in this Section

• SAT reserves interim order
• Lok Sabha passes SEBI Bill
• Autodesk e-nables its design suite
• GE, Bechtel have to wait to recover equity in DPC
• DBL to give thrust to microcredit
• UTI Bank cuts floating rate for housing loans
• MRO-TEK H1 PAT up
• Pfizer finalises pact for Protinex brand
• Stock Market Index
• Exchange rates
• Bullion rates
• Nalco dividend
• Punjab tops in FDI in textile sector
• Rational signs MoU with Kerala Govt.
• Export House status for Elder Pharma
• Wipro Infotech gets Cisco's certification
• NIIT arm bags $10m BPO order

Copyright © 2002, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu